UNIGE document Scientific Article
previous document  unige:89934  next document
add to browser collection

Traitement de la sclérose en plaques : nouveautés et complications

Published in Revue médicale suisse. 2013, vol. 9, no. 384, p. 940-943
Abstract A new therapeutic era opened for multiple sclerosis (MS) with the appearance of molecules given p.o. and/or molecules with greater efficiency. Early diagnosis is critical, as the time and the choice of therapeutic intervention. The initiation of treatments must be personalized, including the risks associated with MS and those potentially related to the treatment chosen, answering the question <Who, when and how to treat?>. Monitoring tools that allow to objectively evaluate: I) MS activity and aggressiveness for each patient and 2) the safety of treatments and their risks of complications, must be further investigated.
Keywords Drug-Related Side Effects and Adverse ReactionsHumansMultiple Sclerosis/drug therapy
PMID: 23717904
Full text
Article (Published version) (538 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Scléroses en plaques, neuroimmunologie, encéphalite autoimmune expérimentale (843)
(ISO format)
SCHLUEP, Myriam, LALIVE D'EPINAY, Patrice, DU PASQUIER, Renaud Alfred Robert. Traitement de la sclérose en plaques : nouveautés et complications. In: Revue médicale suisse, 2013, vol. 9, n° 384, p. 940-943. https://archive-ouverte.unige.ch/unige:89934

281 hits

0 download


Deposited on : 2016-12-07

Export document
Format :
Citation style :